Catabasis Pharmaceuticals Inc buy stratec
Start price
27.04.18
/
50%
€87.13
Target price
20.06.18
€162.36
Performance (%)
-42.92%
End price
20.06.18
€49.74
Summary
This prediction ended on 20.06.18 with a price of €49.74. The BUY prediction by stratec for Catabasis Pharmaceuticals Inc performed very badly with a performance of -42.92%. stratec has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Catabasis Pharmaceuticals Inc | - | - | - | - |
iShares Core DAX® | -0.168% | 4.802% | 17.488% | 17.061% |
iShares Nasdaq 100 | 2.946% | 3.520% | 23.619% | 36.065% |
iShares Nikkei 225® | 1.319% | 6.746% | 12.949% | 0.580% |
iShares S&P 500 | 2.044% | 3.551% | 23.055% | 39.407% |
Comments by stratec for this prediction
In the thread Catabasis Pharmaceuticals Inc diskutieren
stratec stimmt der fundamentalen Bewertung mit dem Ergebnis 'überbewertet' nicht zu
stratec stimmt am 27.04.2018 der fundamentalen Bewertung mit dem Ergebnis überbewertet nicht zu.
(Vom Mitglied beendet)